Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients
Crossref DOI link: https://doi.org/10.1007/s12032-014-0166-6
Published Online: 2014-08-23
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Formica, Vincenzo
Luccchetti, Jessica
Cunningham, David
Smyth, Elizabeth C.
Ferroni, Patrizia
Nardecchia, Antonella
Tesauro, Manfredi
Cereda, Vittore
Guadagni, Fiorella
Roselli, Mario
Text and Data Mining valid from 2014-08-23